Neurocrine Biosciences Inc

NASDAQ:NBIX

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NBIX's stock price target?

Price Target

196.07 USD

According to Wall Street analysts, the average 1-year price target for NBIX is 196.07 USD with a low forecast of 145.44 USD and a high forecast of 258.3 USD.

What is the Revenue forecast for Neurocrine Biosciences Inc?

Projected CAGR

13%

Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for Neurocrine Biosciences Inc?

Projected CAGR

13%

The compound annual growth rate for Gross Profit over the next 8 years is 13%.

What is the Operating Income forecast for Neurocrine Biosciences Inc?

Projected CAGR

26%

Over the last 13 years, the compound annual growth rate for Operating Income has been 53%. The projected CAGR for the next 8 years is 26%.

What is the Pre-Tax Income forecast for Neurocrine Biosciences Inc?

Projected CAGR

38%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 46%. The projected CAGR for the next 3 years is 38%.

What is the Net Income forecast for Neurocrine Biosciences Inc?

Projected CAGR

30%

Over the last 13 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 30%.